NK

Neo Kuma Ventures

Europe, England, United Kingdom, London

Description

Psychedelic Healthcare Investment Fund

Investor Profile

Neo Kuma Ventures has made 7 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Seed (57%)
  • Series A (14%)
  • Convertible Note (14%)
  • Pre Seed (14%)

Country Focus

  • United Kingdom (57%)
  • United States (43%)

Industry Focus

  • Health Care
  • Personal Health
  • Biotechnology
  • Information Technology
  • Gaming
  • Mental Health
  • Virtual Reality
  • Wellness
  • Medical
  • Continuing Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Neo Kuma Ventures frequently co-invest with?

Lionheart Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Heron Rock Fund
North America, Ontario, Canada, Ottawa
Co-Investments: 1
MITON
Europe, Hlavni mesto Praha, Czech Republic, Prague
Co-Investments: 1
Reflex Capital
Europe, Hlavni mesto Praha, Czech Republic, Prague
Co-Investments: 1
Tabula Rasa Ventures
North America, New York, United States, New York
Co-Investments: 1
JLS Fund
North America, New York, United States, New York
Co-Investments: 2
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 2
PS
North America, Illinois, United States, Highland Park
Co-Investments: 4
Bridge Builders Collaborative
North America, Minnesota, United States, Minneapolis
Co-Investments: 1
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 2

Which angels does Neo Kuma Ventures often collaborate with?

MM
North America, Texas, United States, Houston
Shared Deals: 1
SB
North America, California, United States
Shared Deals: 1
BO
Europe, England, United Kingdom, London
Shared Deals: 1
EE
North America, Florida, United States, Miami
Shared Deals: 1
CS
North America, New York, United States, New York
Shared Deals: 1
HG
North America, California, United States, San Francisco
Shared Deals: 1
DM
Europe, United Kingdom
Shared Deals: 1
Sanjay Singhal
North America, Ontario, Canada, Toronto
Shared Deals: 1
AC
Europe, Berlin, Germany, Berlin
Shared Deals: 1
RG
North America, Nevada, United States, Crystal Bay
Shared Deals: 1

What are some of recent deals done by Neo Kuma Ventures?

Syndi Health

London, England, United Kingdom

Outcome-driven digital health recommendation platform

Health CareMachine Learning
Pre SeedFeb 7, 2023
Amount Raised: $1,988,934
Kanna Health

Sevenoaks, Kent, United Kingdom

Developing novel therapeutics from the kanna plant

Biotechnology
Convertible NoteMay 15, 2022
Amount Raised: $3,799,695
Fluence

New York, New York, United States

Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy.

Continuing EducationE-LearningEducationPsychologyTraining
SeedNov 4, 2021
Amount Raised: $1,600,000
wavepaths

London, England, United Kingdom

Wavepaths creates accessible tools in psychedelic therapy intended for inner exploration and personal transformation.

Health CareInformation TechnologyPersonal Health
SeedNov 3, 2021
Amount Raised: $4,500,000
Journey Clinical

New York, New York, United States

Journey Clinical is a platform that provides services to member psychotherapy practices which are independently owned and operated.

Health CareMedical
SeedSep 16, 2021
Amount Raised: $3,000,000
Monument Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

BiotechnologyHealth CarePharmaceutical
SeedJul 1, 2021
Amount Raised: $3,611,747
TRIPP

Los Angeles, California, United States

TRIPP is a digital psychedelic wellness platform that uses virtual and augmented reality focusing on mental health.

GamingMental HealthPersonal HealthVirtual RealityWellness
Series AJun 25, 2021
Amount Raised: $11,000,000